https://www.nice.org.uk/guidance/ta229/documents/macular-oedema-retinal-vein-occlusion-dexamethasone-review-decision-january-2015
Background information | Dexamethasone intravitreal implant for the treatment of macular oedema...
Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating macular oedema following retinal vein occlusion in adults
background informationintravitreal implantthe treatmentdexamethasone
https://www.nice.org.uk/guidance/ta229/chapter/4-Consideration-of-the-evidence
4 Consideration of the evidence | Dexamethasone intravitreal implant for the treatment of macular...
Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating macular oedema following retinal vein occlusion in adults
of theintravitreal implant4considerationevidence
https://www.nice.org.uk/guidance/ta229/resources
Tools and resources | Dexamethasone intravitreal implant for the treatment of macular oedema...
Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating macular oedema following retinal vein occlusion in adults
tools and resourcesintravitreal implant
https://www.medicines.org.uk/emc/product/5654/smpc
OZURDEX 700 micrograms intravitreal implant in applicator - Summary of Product Characteristics...
OZURDEX 700 micrograms intravitreal implant in applicator - Summary of Product Characteristics (SmPC) by AbbVie Ltd
intravitreal implantozurdex700micrograms
https://www.biospace.com/surmodics-inc-i-vation-tm-intravitreal-implant-six-month-clinical-study-data-presented-at-the-b-american-society-of-retina-specialists-b-meeting
SurModics Inc. I-vation(TM) Intravitreal Implant Six Month Clinical Study Data Presented At The...